BIOLOG, INC.
21124 CABOT BLVD.
HAYWARD, CA 94545
510-785-2564
www.biolog.com
MATERIAL SAFETY DATA SHEET
IDENTIFICATION
PRODUCT #: 73014
NAME: Sodium Salicylate 100mM
CAS#: 54-21-7
MF: C7H5NAO3
EC NO: 200-198-0 SYNONYMS
ALYSINE * ARDALL* AROALL* BENZOIC ACID ,2 鈥揌YDROXY-, MONOSODIUM SALT (9CI)*
CLIN* DIURETIN* ENTEROSALICYL* ENTEROSALIL* 2-HYDROXYBENZOIC ACID
MONOSODIUM SALT* O-HYDROXYBENZOIC SODIUM SALT* IDOCYL NOVUM*
KERASALICYL* KEROSAL* MAGSALYL* MONOSODIUM 2-HYDROXYBENZOATE* NADISAL*
NATRIUM SALICYLAT (GERMAN)* NEO-SALCYL* PARBOCYL-REV* SALICYLIC ACID,
SODIUM SALT* SALISOD* SALSONIN* SODIUM O-HYDROXYBENZOATE* SODIUM
SALICYALTE* SODIUM SALICYLIC ACID*
PHYSICAL DATA
APPEARANCE AND ODOR: CLEAR LIQUID
TOXICITY HAZARDS
ACUTE EFFECTS MAY BE HARMFUL BY INHALATION, INGESTION, OR SKIN ABSORPTION.
CAUSES EYE AND SKIN IRRITATION.
MATERIAL IS IRRITATING TO MUCOUS MEMBRANES AND UPPER RESPIRATORY TRACT.
RTECS # VO5075000 SALICYLIC ACID, MONOSODIUM SALT
TOXICITY DATA ORL-HMN LDLO: 700 MG/KG NEJMAG 232, 617, 45
ORL-RAT LD 50: 930 MG/KG SRTCAC 36 (1-4), 10, 89
IPR-RAT LD 50: 542 MG/KG KSRNAM 13, 791, 79
ORL-MUS LD 50: 540 MG'KG ARZNAD 5, 572, 55
IPR-MUS LD 50: 500 MG/KG STRAAA 127, 245, 65
SCU-MUS LD 50: 550 MG/KG ARZNAD 8, 25, 58
IVN-MUS LD 50: 560 MG/KG KSRNAM 13, 791, 79
IMS-MUS LD 50: 760 MG'KG APSVAM 59, 517, 70
IVN-DOG LD 50: 562 MG/KG AIPTAK 149, 571, 64
ORL-RBT LD 50: 1700 MG'KG JPETAB 89, 205, 47
IVN-RBT LD 50: 415 MG/KG KSRNAM 13, 791, 79
REVIEWS, STANDARDS, AND
REGULATIONS OEL=MAK
NOHS 1974: HZD 84407; NIS 6; TNF 1892; NOS 16; TNE 16641
NOES 1983: HZD 84407; NIS 9; TNF 2056; NOS 18; TNE 29395; TFE 19141
EPA TSCA SECTION 8(B) CHEMICAL INVENTORY
TARGET ORGAN DATA BEHAVIORAL (TOXIC PSYCHOSIS)
BEHAVIORAL (CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD)
BEHAVIORAL (EXCITEMENT)
BEHAVIORAL (MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL (ANALGESIA)
CARDIAC (ARRYTHMIAS)
LUNGS, THORAX OR RESPIRATION (DYSPNAE)
LUNGS, THORAX OR RESPIRATION (RESPIRATORY STIMULATION)
LUNGS, THORAX OR RESPIRATION (OTHER CHANGES)
SKIN AND APPENDAGES (SWEATING)
MATERNAL EFFECTS (PARTURITION)
EFFECTS ON FERTILITY (POST-IMPLANTATION MORTALITY)
EFFECTS ON EMBRYO OR FETUS (FETOTOXICITY)
EFFECTS ON EMBRYO OR FETUS (FETAL DEATH)
EFFECTS ON EMBRYO OR FETUS (OTHER EFFECTS TO EMBRYO OR FETUS)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (CENTRAL NERVOUS SYSTEM)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (EYE, EAR)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (CRANIOFACIAL)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (BODY WALL)
Page 1 of 3
MS Na Salicylate 73014
Effective Date: 02 March, 2005
BIOLOG, INC.
21124 CABOT BLVD.
HAYWARD, CA 94545
510-785-2564
www.biolog.com
MATERIAL SAFETY DATA SHEET
IDENTIFICATION
PRODUCT #: 73014
NAME: Sodium Salicylate
TARGET ORGAN DATA (CONT.) SPECIFIC DEVELOPMENTAL ABNORMALITIES ( MUSCULOSKELETAL SYSTEM)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (CARDIOVASCULAR SYSTEM)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (OTHER DEVELOPMENTAL ABNORMALITIES)
EFFECTS ON NEWBORN (STILLBIRTH)
EFFECTS ON NEWBORN (WEANING OR LACTATION INDEX)
EFFECTS ON NEWBORN (BEHAVIORAL)
ONLY SELECTED REGISTRY OF TOXIC EFFECTS OF CHEMICAL SUBSTANCES (RTECS) DATA IS
PRESENTED HERE. SEE ACTUAL ENTRY IN RTECS FOR COMPLETE INFORMATION.
HEALTH HAZARD DATA
PRECAUTIONARY HARMFUL; HARMFUL BY INHALATION, IN CONTACT WITH SKIN AND IF SWALLOWED;
STATEMENTS IRRITATING TO EYES, RESPIRATORY SYSTEM AND SKIN;
IN CASE OF CONTACT WITH EYES, RINSE IMMEDIATELY WITH PLENTY OF WATER AND SEEK
MEDICAL ADVICE; WEAR SUITABLE PROTECTIVE CLOTHING.
FIRST AID IN CASE OF CONTACT, IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS OF WATER FOR AT
LEAST 15 MINUTES.
IN CASE OF CONTACT, IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS AMOUNTS OF
WATER.
IF INHALED, REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL RESPIRATION. IF
BREATHING IS DIFFICULT, GIVE OXYGEN.
IF SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDING PERSON IS CONSCIOUS. CALL A
PHYSICIAN.
WASH CONTAMINATED CLOTHING BEFORE REUSE.
FIRE AND EXPLOSION HAZARD DATA
EXTINGUISHING MEDIIA WATER SPRAY OR CARBON DIOXIDE, DRY CHEMICAL POWDER OR APPROPRIATE FOAM.
SPECIAL FIREFIGHTING
PROCEDURES WEAR SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE CLOTHING TO PREVENT
CONTACT WITH SKIN AND EYES.
UNUSUAL FIRE AND EXPLOSIONS
HAZARD EMITS TOXIC FUMES UNDER FIRE CONDITIONS
REACTIVITY DATA
INCOMPATIBIITIES STRONG OXIDIZING AGENTS
STRONG ACIDS
MAY DISCOLOR ON EXPOSURE TO LIGHT.
HAZARDOUS COMBUSTION OR
DECOMPOSITION PRODUCTS TOXIC FUMES OF: CARBON MONOXIDE, CARBON DIOXIDE
EXPOSURE CONTROLS/ PERSONAL PROTECTION
NIOSH/MSHA-APPROVED RESPIRATOR, CHEMICAL SAFETY GOGGLES, COMPATIBLE CHEMICAL-
RESISTANT GLOVES.
SAFETY SHOWER AND EYE BATH, MECHANICAL EXHAUST REQUIRED.
AVOID CONTACT AND INHALATION, DO NOT GET IN EYES, ON SKIN, ON CLOTHING.
WASH THROUGHLY AFTER HANDLING, IRRITANT, KEEP TIGHTLY CLOSED, LIGHT SENSITIVE.
STORE IN A COOL DRY PLACE.
ACCIDENT RELEASE MEASURES WEAR SELF-CONTAINED BREATHING APPARATUS, RUBBER BOOTS AND HEAVY RUBBER GLOVES.
SWEEP UP, PLACE IN A BAG AND HOLD FOR WASTE DISPOSAL, AVOID RAISING DUST.
VENTILATE AREA AND WASH SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE.
Page 2 of 3
MS Na Salicylate 73014
Effective Date: 02 March, 2005
BIOLOG, INC.
21124 CABOT BLVD.
HAYWARD, CA 94545
510-785-2564
www.biolog.com
MATERIAL SAFETY DATA SHEET
IDENTIFICATION
PRODUCT #: 73014
NAME: Sodium Salicylate
DISPOSAL CONSIDERATIONS DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL
INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER. OBSERVE ALL FEDERAL, STATE
AND LOCAL ENVIRONMENTAL REGULATIONS.
EUROPEAN REGULATORY INFORMATION
HARMFUL R 20/21/22; HARMFUL BY INHALATION, IN CONTACT WITH SKIN AND IF SWALLOWED.
R36/37/38; IRRITATING TO EYES, RESPIRATORY SYSTEM AND SKIN S 26; IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF WATER AND SEEK MEDICAL ADVICE. S 36; WEAR
SUITABLE PROTECTIVE CLOTHING.
DISCLAIMER
The information, data, and recommendations contained herein are believed to be accurate. Biolog,Inc. makes no
warranty of any kind whatever with respect thereto and disclaims all liability from reliance thereon. We reserve the right to
revise this MSDS periodically as new information becomes available.
Page 3 of 3
MS Na Salicylate 73014
Effective Date: 02 March, 2005
|